Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(75.0%)
Phase 1
1(25.0%)
4Total
Phase 2(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06580678Phase 2Completed

A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries

Role: collaborator

NCT06464939Phase 2Completed

Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

Role: lead

NCT06264453Phase 2Completed

A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

Role: lead

NCT04804514Phase 1Completed

Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients

Role: lead

All 4 trials loaded